Product Reports Resources Pricing Login Book a demo

Hyperfine

Health Tech & Medtech · Guilford, United States · Founded 2014

Portable, ultra-low field MR brain imaging system enabling timely clinical decisions at the point of care MoreLess

Hyperfine, Inc. is a pioneering health technology company that has developed the Swoop system, the first FDA-cleared, portable, ultra-low field magnetic resonance imaging (MRI) system. The Swoop system is designed to bring MR brain imaging directly to the patient's bedside, particularly in intensive care units, thereby eliminating the need to transport critically ill patients to radiology departments. This innovation allows for timelier treatment decisions, quicker patient discharges, and more efficient use of hospital staff and resources. The system's open and safe design also enables family members to stay close and provide comfort during imaging procedures. Hyperfine's primary clients include hospitals, clinics, and other healthcare facilities that require accessible and efficient diagnostic imaging solutions. The company operates in the global healthcare market, focusing on improving patient care through advanced imaging technology. Hyperfine generates revenue by selling its Swoop system and related services to healthcare providers. The business model is centered around providing a cost-effective, portable MRI solution that enhances clinical decision-making and patient outcomes.

Keywords: portable MRI, ultra-low field, brain imaging, point-of-care, FDA-cleared, healthcare technology, patient care, diagnostic imaging, intensive care, clinical efficiency.

Valuation $0–100M
Revenue $10–50M
Headcount 100–500
Total funding $100–500M
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Hyperfine and the history behind them.

Company overview

Hyperfine company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2014
Headquarters
Guilford, United States
Employees
121
Open positions
None listed
Dealroom signal
68.4
client focusb2btechnologyDeep Techsub industryMedical Devicesbusiness modelManufacturingindustryHealthsectorNeurologysectorRadiologysectorMedical ImagingsectorSPAC TargetsectorSPAC IPO AnnouncedsectorHard TechsectorDT and LSsectorscience-based

Valuation & funding

Hyperfine funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
POST IPO DEBTDebt Mar 2026 $0 Horizon Technology Finance Corporation
GRANTOther financing Nov 2025 $3.7M Bill & Melinda Gates Foundation
IPOOther financing Oct 2025 $18M $103M Undisclosed
POST IPO EQUITYOther financing Feb 2025 $6M Undisclosed
GRANTOther financing May 2023 $3M Bill & Melinda Gates Foundation
SPAC PRIVATE PLACEMENTOther financing Jul 2021 Bain Capital · Deerfield · Avidity Partners · HealthCor Management
SPAC IPOOther financing Jul 2021 HealthCor Catalio Acquisition Corp
SERIES DOther financing Feb 2021 Altium Capital · Colle Capital Partners · Huami Technology · Axiom Associates
GRANTOther financing Nov 2020 Bill & Melinda Gates Foundation
SERIES COther financing Jan 2017 Undisclosed
Showing 10 recorded eventsUnlock the complete deal history →

Financials

Revenue, earnings and profit over time

Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.

YearRevenueGrowthEBITDAMargin
2026 $20M +48.6% −$31M -154.9%
2025 $14M +5.2% −$37M -271.5%
2024 $13M +16.8% −$42M -327.5%
2023 $11M +61.9% −$47M -426.6%
2022 $6.8M +355.5% −$73M -1069.3%
2021 $1.5M +408.8% −$64M -4287.6%
2020 $294K −$23M -7891.8%
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Hyperfine website traffic

Latest recorded traffic for Hyperfine is 10K monthly website visits, up 185.7% over the last three months. Hyperfine's team grew 0% over the past year.

Latest monthly visits10K 3-month web change+185.7% 1-year team growth0%
Monthly website visits67 observations · Aug 2020–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Hyperfine compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Hyperfine's talent

Book a demo to see the people
Team profiled 15 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

16 investors on Hyperfine's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 1 investor entered at this stage
Bill & Melinda Gates Foundation
Series B+ 15 investors entered at this stage
Altium Capital
Colle Capital Partners
Huami Technology
Axiom Associates
Lss Capital Markets
Nextrans Korea
Bain Capital
Deerfield
Avidity Partners
HealthCor Management
Perceptive Advisors
Eldridge
Catalio Capital Management
HealthCor Catalio Acquisition Corp
Horizon Technology Finance Corporation

Global footprint

Where Hyperfine has talent and traffic

Workforce by country
4 countries with
team presence
🇺🇸 United States96%
🇬🇧 United Kingdom2%
🇩🇪 Germany1%
🇮🇹 Italy1%
4 countries shown

In the news

Latest news about Hyperfine

Recent press, funding announcements, and product moves mentioning Hyperfine — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Hyperfine

An AI-synthesized read of the highest-engagement posts about Hyperfine on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Hyperfine’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.